v3.26.1
Held for Sale and Discontinued Operations
 6 Months Ended
Jun. 30, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Held for Sale and Discontinued Operations Disposals
On May 1, 2025, the Company closed the disposition of an incontinence business that was included in its Wellness at Home segment. In connection with the closing, the Company received gross proceeds of $69.1 million.
On June 9, 2025, the Company closed the disposition of an infusion business that was included in its Wellness at Home segment. In connection with this transaction, the Company received gross proceeds of $53.5 million and was entitled to potential contingent payments of up to $12.5 million based upon the achievement of certain conditions in accordance with the terms of the sale agreement. In June 2026, the Company received $6.3 million related to the contingent payments, which is included in gain on sale of businesses recognized in the consolidated statements of operations for the three and six months ended June 30, 2026. The Company does not expect to receive the remaining contingent payments.
The dispositions described above did not represent a strategic shift for the Company. As such, they did not meet the requirements to be classified and presented as discontinued operations.
The following table presents the pre-tax gain recognized during the three and six months ended June 30, 2025 associated with the dispositions described above (in thousands):
Gross sales proceeds$122,336 
Net assets sold(90,111)
Total $32,225 
The carrying value of the net assets sold at their respective closing dates associated with the dispositions described above were as follows (in thousands):
Cash$5,161 
Accounts receivable12,667 
Inventory1,770 
Prepaid and other current assets1,142 
Equipment and other fixed assets, net909 
Operating lease right-of-use assets776 
Goodwill80,943 
Identifiable intangible assets, net2,435 
Other assets11 
Accounts payable and accrued expenses(13,451)
Operating lease liabilities(802)
Other liabilities(1,450)
Total$90,111 
Held for Sale and Discontinued Operations
In June 2026, the Company's board of directors approved the divestiture of the Company's Diabetes Health business. On July 19, 2026, the Company entered into a definitive agreement to sell the Diabetes Health business for $235.0 million in cash, subject to customary purchase price adjustments. The transaction is expected to close in the first quarter of 2027, subject to regulatory review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and other customary closing conditions. The Diabetes Health business provides medical devices, including continuous glucose monitors and insulin pumps, and related services to patients for the treatment of diabetes. As a result of this transaction, the Diabetes Health business met the criteria to be reported as discontinued operations. Therefore, the Company has reported the results of the Diabetes Health business, including the results of operations, and related assets and liabilities, as discontinued operations for all periods presented herein.
The following table summarizes the major classes of assets and liabilities classified as held for sale (in thousands):
June 30,
2026		December 31,
2025
Assets
Inventory$34,219 $36,354 
Equipment and other fixed assets, net6,413 6,763 
Goodwill83,801 83,801 
Identifiable intangible assets, net43,665 49,347 
Total assets held for sale - discontinued operations$168,098 $176,265 
Liabilities
Contract liabilities$560 $504 
Total liabilities held for sale - discontinued operations$560 $504 
The following table summarizes the results of discontinued operations (in thousands):
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Net revenue$154,440 $143,272 $294,365 $276,607 
Costs and expenses:
Cost of net revenue132,619 124,402 256,675 242,877 
General and administrative expenses2,378 2,173 4,402 4,132 
Depreciation and amortization, excluding patient equipment depreciation2,893 3,139 5,828 6,281 
Income from discontinued operations before income taxes$16,550 $13,558 $27,460 $23,317 
Income tax expense5,163 3,111 7,096 6,447 
Net income from discontinued operations, net of tax$11,387 $10,447 $20,364 $16,870 
The following table provides significant non-cash operating and investing cash flow information for the Company's discontinued operations:
Six Months Ended June 30,
20262025
Operating activities:
Depreciation and amortization, including patient equipment depreciation$11,083 $10,839 
Reduction in the carrying amount of operating lease right-of-use assets267 450 
Equity-based compensation325 225 
Investing activities:
Purchases of equipment and other fixed assets$5,016 $4,152